Jonathan Gilthorpe

Umeå University, Umeå, Västerbottens län, Sweden 
"Jonathan Gilthorpe"
Mean distance: (not calculated yet)


Sign in to add trainee
Sarah M Shapley research assistant 2018-2018 Umeå University
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Månberg A, Skene N, Sanders F, et al. (2021) Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset. Nature Medicine
Månberg A, Skene N, Sanders F, et al. (2021) Altered perivascular fibroblast activity precedes ALS disease onset. Nature Medicine. 27: 640-646
Palaniappan TK, Šlekienė L, Jonasson AK, et al. (2020) CAM-Delam: an in vivo approach to visualize and quantify the delamination and invasion capacity of human cancer cells. Scientific Reports. 10: 10472
Cunningham TJ, Fisher E, Fratta P, et al. (2020) DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base. The Crispr Journal. 3: 75-77
Muthu M, Kumar R, Syed Khaja AS, et al. (2019) Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism. Cancers. 11
Alhouayek M, Sorti R, Gilthorpe JD, et al. (2019) Role of pannexin-1 in the cellular uptake, release and hydrolysis of anandamide by T84 colon cancer cells. Scientific Reports. 9: 7622
Keskin I, Forsgren E, Lehmann M, et al. (2019) The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension. Acta Neuropathologica
Singel KL, Grzankowski KS, Khan ANMNH, et al. (2018) Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer. British Journal of Cancer
Bergman J, Burman J, Gilthorpe JD, et al. (2018) Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study. Neurology. 91: e1893-e1901
Paré B, Lehmann M, Beaudin M, et al. (2018) Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Scientific Reports. 8: 14223
See more...